Gilead Sciences
Gilead Sciences is a biopharmaceutical company that develops and commercialises therapeutics products. Gilead's Irish operations are responsible for manufacturing, quality control, packaging, and the release and distribution of the company's products in the EU and other international locations.
Financial Data
-
31st Dec 18 Source: CRO
- €2.1 billion turnover
-
€132.9 million
profit - 375 employees
-
31st Dec 17 Source: Estimated
- €2.3 billion turnover
- 250 employees
- 9 more years available »
Ranking
By Turnover
(€2.1 billion)- 53rd in Top Companies
- 10th in Health
- 8th in Pharma
By Employees
(375)- 438th in Top Companies
- 64th in Health
- 42nd in Pharma
-
- 375
- €2.1 billion
Employees
- David Cadogan Vice President}
Latest News
- Oct 21 Declan Ganley denies Donald Trump trying to swing lucrative 5G contract for Rivada
- Oct 21 Amarenco Solar borrows €12m to finance growth
- Oct 21 Timber lobby says ‘zero evidence’ of Government clearing licence backlog
- Oct 21 Brexit: UK and EU agree to intensify talks in rush for deal
- Oct 21 Paschal Donohoe expects ‘some kind’ of OECD digital tax agreement in 2021